Sunzen Biotech
Sunzen Biotech Bhd is a Malaysian public biotechnology company (klse:SUNZEN) that provides animal health care products and has expanded into the ophthalmic industry via its 70% acquisition of Eye Nation Medical Sdn Bhd in 2024.
- Company typePublic
- Founded1998
- HeadquartersShah Alam, Malaysia
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Sunzen Biotech firmographics
Firmographics- Name
- Sunzen Biotech
- Legal name
- Sunzen Biotech Bhd
- Website
- https://sunzen.com.my
- Company type
- Public
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Sunzen Biotech Bhd is a Malaysian public biotechnology company (klse:SUNZEN) that provides animal health care products and has expanded into the ophthalmic industry via its 70% acquisition of Eye Nation Medical Sdn Bhd in 2024.
- Ownership category
- akta.pro rank
Sunzen Biotech industry classification
Industry- Product category
- Animal Health & Biotechnology
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Ophthalmic Goods Manufacturing (339115)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Ophthalmic Goods (3851), Pharmaceutical Preparations (2834)
- akta.pro industry
- Manufacturing, Private Label & Co-Manufacturing for Animal DietsOphthalmology Specialty PharmaceuticalsOphthalmology Pharmaceuticals
Keywords
Where Sunzen Biotech is headquartered
LocationHeadquarters
- HQ city
- Shah Alam
- HQ country
- Malaysia
- HQ region
- Asia
Markets served
Sunzen Biotech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales
Sunzen Biotech product offering
Product offeringCore offering
Sunzen Biotech is a Malaysian biotechnology company that manufactures and supplies animal health care products, including nutrition and wellness formulations for the livestock and companion animal markets. In February 2024 the company acquired a 70% stake in Eye Nation Medical Sdn Bhd (RM6.37 million), extending its portfolio into ophthalmic eye care products and services for the medical and consumer eye-care markets.
Differentiator
Problem solved
Functional benefit
Products and services
- Animal health care products
- Ophthalmic eye care products and services
Companies that use Sunzen Biotech
Customer profileSegments1 record
Ideal customer profiles2 records
Sunzen Biotech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Sunzen Biotech partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Eye Nation Medical Sdn BhdcoreSunzen Biotech Bhd acquired a 70% stake in Eye Nation Medical Sdn Bhd for RM6.37 million. This strategic acquisition enables Sunzen to expand into the ophthalmic industry and access new markets in Malaysia. The acquisition leverages Eye Nation's established industry relationships and certifications to improve Sunzen's financial performance and support long-term growth strategies.
Scale indicators1 record
Sunzen Biotech competitors and assessment
Company assessmentBroad incumbents
- Virbac: Global animal health pharmaceutical company with a broad portfolio across companion and production animals. A useful comparable for Sunzen's animal health biotech positioning at international scale.
- Elanco Animal Health: Public animal health company focused on livestock and companion animal therapeutics. Comparable to Sunzen as a public peer in animal health, though operating with a much larger product portfolio and global footprint.
- Alcon: Global leader in eye care devices and ophthalmic pharmaceuticals. Comparable to the ophthalmic vertical Sunzen is entering through its Eye Nation acquisition, though operating at massively greater scale.
- Vetoquinol: Independent animal health pharmaceutical company with products across companion animals and livestock. Comparable to Sunzen's animal health foundation and as an independent (non-major) public peer.
- Bausch + Lomb: Global ophthalmic goods manufacturer and supplier of vision care products. Directly comparable to Sunzen's strategic expansion into the ophthalmic sector via Eye Nation Medical.
- Dechra Pharmaceuticals: Specialty animal health pharmaceutical company with a portfolio focused on companion animal therapeutics. Comparable to Sunzen's specialty positioning in animal health products.
- IDEXX Laboratories: Major player in veterinary diagnostics and animal health. Comparable to Sunzen's biotechnology-driven animal health focus, though focused on diagnostic platforms rather than therapeutics.
- Zoetis: Global leader in animal health medicines and vaccines. Comparable to Sunzen's legacy animal health care products business, but operating at vastly greater scale across pharmaceuticals, diagnostics, and biologics.
Regional players
- Pharmaniaga: Malaysian pharmaceutical and biologics manufacturer listed on Bursa Malaysia. Comparable to Sunzen as a Malaysia-based biotech/pharmaceutical peer, with overlapping regional distribution and regulatory positioning.
Emerging players
- Heska (Mars Petcare): Veterinary diagnostics and specialty animal health company, now part of Mars Petcare. Comparable to Sunzen as a focused animal health biotech, though with stronger diagnostic specialization.
Market position
Customer concentration
Sunzen Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sunzen Biotech leadership team
Management profileNumber of profiles
Sunzen Biotech subsidiaries and ownership
Company hierarchySubsidiaries1 record
Sunzen Biotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sunzen Biotech M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sunzen Biotech
What does Sunzen Biotech do?
Sunzen Biotech is a Malaysian biotechnology company that manufactures and supplies animal health care products, including nutrition and wellness formulations for the livestock and companion animal markets. In February 2024 the company acquired a 70% stake in Eye Nation Medical Sdn Bhd (RM6.37 million), extending its portfolio into ophthalmic eye care products and services for the medical and consumer eye-care markets.
Is Sunzen Biotech a public or private company?
Sunzen Biotech is a public company. It is classified as public and is currently operating.
When was Sunzen Biotech founded?
Sunzen Biotech was founded in 1998. It employs 11 to 50 people.
Where is Sunzen Biotech based?
Sunzen Biotech is headquartered in Shah Alam, Malaysia, in the Asia region.
Who are Sunzen Biotech's main competitors?
Broad incumbents on record are Virbac, Elanco Animal Health, Alcon, Vetoquinol, Bausch + Lomb, Dechra Pharmaceuticals, IDEXX Laboratories and Zoetis. Pharmaniaga is listed as a regional player. Heska (Mars Petcare) is listed as an emerging player.
Does Sunzen Biotech have an API?
No public API is recorded for Sunzen Biotech.
What industry is Sunzen Biotech in?
Sunzen Biotech's product category is Animal Health & Biotechnology. Its primary akta.pro industry code is HLAMAHAO, Manufacturing, Private Label & Co-Manufacturing for Animal Diets, with a secondary code of HLAIACAK, Ophthalmology Specialty Pharmaceuticals. Its NAICS code is 325414 and its SIC code is 2836.